All Comments by William Klunk

  1. In Down's Syndrome, Blood P-Tau217 Detects Plaques and Tangles
  2. Double Whammy: APP Uppsala Deletion Ups Aβ and Its Aggregation Propensity
  3. iSILK Tracks Growth of Mouse Plaques at Peptide Level
  4. In the Wake of COVID-19: Trials Interrupted, Delayed, Cancelled
  5. Coronavirus Takes Its Toll on Alzheimer’s Clinical Studies
  6. Topline Result for First DIAN-TU Clinical Trial: Negative on Primary
  7. Flortaucipir Imaging Distinguishes Alzheimer’s From Other Disorders
  8. NIH Director Announces $100M Prevention Trial of Genentech Antibody
  9. 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease.
  10. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease.
  11. Brain Aβ Patterns Linked to Brain Energy Metabolism
  12. Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease.
  13. PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer's disease.
  14. Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease.
  15. Reducing AD-like pathology in 3xTg-AD mouse model by DNA epitope vaccine - a novel immunotherapeutic strategy.